Reviva Pharmaceuticals
(NASDAQ) RVPH
Reviva Pharmaceuticals Financials at a Glance
Market Cap
$9.29M
Revenue (TTM)
$0.00
Net Income (TTM)
$19.86T
EPS (TTM)
$-6.75
P/E Ratio
-0.11
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$0.80
Volume
21,869
Open
$0.80
Price
$0.80
Volume
21,869
Open
$0.80
Previous Close
$0.80
Daily Range
$0.75 - $0.80
52-Week Range
$0.59 - $23.20
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$0.80
Volume
21,869
Open
$0.80
Previous Close
$0.80
Daily Range
$0.75 - $0.80
52-Week Range
$0.59 - $23.20
RVPH News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Reviva Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
14
CEO
Laxminarayan Bhat, PhD
Website
www.revivapharma.comHeadquarters
Cupertino, CA 95014, US
RVPH Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-420%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-9.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$9.29M
Shares Outstanding
12.73M
Volume
21.87K
Short Interest
0.00%
Avg. Volume
439.10K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$20.20T
EBITDA
$20.20T
Operating Cash Flow
$24.59T
Capital Expenditure
$0.00
Free Cash Flow
$24.59T
Cash & ST Invst.
$14.44T
Total Debt
$406.88B
Reviva Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$9.29M
N/A
Market Cap/Employee
$663.35K
N/A
Employees
14
N/A
Net Income
$19.86T
-317356850.6%
EBITDA
$20.20T
-323198626.0%
Quarterly Fundamentals
Net Cash
$14.03T
+107787011.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$406.88B
+88807375.2%
Return on Assets
-1.25%
N/A
Return on Invested Capital
-2.34%
N/A
Free Cash Flow
$24.59T
-270255735.5%
Operating Cash Flow
$24.59T
-270255735.5%